Myocardial infarct size is smaller in dogs with pacing-induced heart failure

Cardiovascular Research

Volumn 32, Issue 2, 1996, Pages 238-247

  Hoskins, Darrell E ^a,b   Ignasiak, Diane P ^a   Saganek, Lori J ^a   Gallagher, Kim P ^a   Peterson, J Thomas ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Blood flow; Cardiomyopathy; Dog; Echocardiography; Heart failure; Microspheres, radioactive; Myocardial infarct size; Tachycardia

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; ECHOCARDIOGRAPHY; HEART FAILURE; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART PACING; HEART RATE; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARDIAC PACING, ARTIFICIAL; DOGS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM;

EID: 0030222249     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00028-4     Document Type: Article

References (51)

1. [1] Armstrong S, Downey JM, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res 1994;28:72-77.
2. [2] Calderone A, Bouvier M, Li K, Juneau C, de-Champlain J, Rouleau JL. Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res 1991;69:332-343.
3. [3] Chow E, Woodard JC, Farrar DJ. Rapid ventricular pacing in pigs: an experimental model of congestive heart failure. Am J Physiol 1990;258:H1603-H1605.
4. [4] Damiano RJ, Tripp HF, Asano T, Small KW, Jones RH, Lowe JE. Left ventricular dysfunction and dilation resulting from chronic supraventricular tachycardia. J Thoracic Cardiovasc Surg 1987;94:135-143.
5. [5] Delehanty JM, Himura Y, Elam H, Hood W Jr, Liang CS. Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. Am J Physiol 1994;266:H903-H905.
6. [6] Downey JM, Cohen MV, Ytrehus K, Liu, Y. Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C. Ann NY Acad Sci 1994;723:82-98.
7. [7] Elsner D, Kromer EP, Riegger. GA. Effects of vagal blockade on neurohumoral systems in conscious dogs with heart failure. J Cardiovasc Pharmacol 1990;15:586-591.
8. [8] Fitzpatrick MA, Rademaker MT, Charles CJ, Yandle TG, Espiner EA, Ikram H. Angiotensin II receptor antagonism in ovine heart failure: acute hemodynamic, hormonal, and renal effects. Am J Physiol 1992;263:H250-H256.
9. [9] Forster C, Naik G, Armstrong PW. Noradrenaline biosynthesis and metabolism during development and recovery from pacing-induced heart failure in the dog. Can J Physiol Pharmacol 1994;72:45-49.
10. [10] Gallagher KP, Buda AJ, Pace D, Gerren RA, Shlafer M. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion. Circulation 1986;73:1065-1076.
11. [11] Hashimi W, Downey JM, Cohen MV. Loss of preconditioning's protection after chronic adenosine exposure is not related to PKC downregulation. J Mol Cell Cardiol 1994;26:CLII.
12. [12] Heyman MA, Payne BD, Hoffman JIE, Rudolf AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis 1977;20:55.
13. [13] Ishikawa Y, Sorota S, Kiuchi K, et al. Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs. J Clin Invest 1994;93:2224-2229.
14. [14] Jennings RB, Murry CE, Reimer KA. Preconditioning myocardium with ischemia. Cardiovasc Drugs Ther 1991;5:933-938.
15. [15] Juneau C, Calderone A, Rouleau JL. Myocardial beta-adrenergic and mechanical properties in pacing-induced heart failure in dogs. Am J Physiol 1992;262:H1458-H1467.
16. [16] Kiuchi K, Shannon RP, Komamura K, et al. Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest 1993;91:907-914.
17. [17] Koyanagi S, Eastham C, Marcus ML. Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs. Circulation 1982;65(6):1192-1197.
18. [18] Laflamme AK, Caille G, Cardinal R, Croteau D, Lamoureux C, Lambert C. Effect of congestive heart failure on clentiazem pharmacokinetics in a dog model. Biopharm Drug Dispos 1992;13:513-520.
19. [19] Li GC, Vasquez JA Gallagher, KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 1990;82:609-619.
20. [20] Liu Y, Cohen MV, Downey JM. Chelerythrine, a highly selective protein kinase C inhibitor blocks the anti-infarct effect of ischemic preconditioning in rabbit hearts [Letter]. Cardiovasc Drugs Ther 1994;8:881-882.
21. [21] Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 1993;88:1273-1278.
22. [22] Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994;26:61-68.
23. [23] Margulies KB, Hildebrand F Jr, Lerman A, Perrella MA, Burnett J Jr. Increased endothelin in experimental heart failure. Circulation 1990;82:2226-2230.
24. [24] Marzo KP, Frey MJ, Wilson JR, et al. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ Res 1991;69:1546-1556.
25. [25] Masaki H, Imaizumi T, Ando S, et al. Production of chronic congestive heart failure by rapid ventricular pacing in the rabbit. Cardiovasc Res 1993;27:828-831.
26. [26] Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
27. [27] Montgomery C, Hamilton N, Ianuzzo, CD. Energy status of the rapidly paced canine myocardium in congestive heart failure. J Appl Physiol 1992;73:2363-2367.
28. [28] Muller KD Sass, S Gottwik, MG, Schaper W. Effect of myocardial oxygen consumption on infarct size in experimental coronary artery occlusion. Basic Res Cardiol 1982;77:170-181.
29. [29] Newman WH, Grossman SJ, Frankis MB, Webb JG. Increased myocardial adenosine release in heart failure. J Mol Cell Cardiol 1984;16:577-580.
30. [30] Ovize M, Kloner RA, Przyklenk K. Stretch preconditions canine myocardium. Am J Physiol 1994;266:H137-H146.
31. [31] Pierpont ME, Foker JE, Pierpont GL. Myocardial carnitine metabolism in congestive heart failure induced by incessant tachycardia. Basic Res Cardiol 1993;88:362-370.
32. [32] Rahko PS, Liedtke AJ. Myocardial metabolism in a canine model of tachypaced induced heart failure. Circulation 1992;86:1284.
33. [33] Reimer KA, Jennings RB, Cobb FR, et al. Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models. Circ Res 1985;56:651-665.
34. [34] Riegger AJ. [ACE inhibition: mechanisms of cardioprotection in chronic experimental heart failure]. Klin Wochenschr 1991;24:20-23.
35. [35] Rouslin W, Broge CW, Grupp IL. ATP depletion, mitochondrial functional loss during ischemia in slow and fast heart-rate hearts. Am J Physiol 1990;259:H1759-H1766.
36. [36] Shannon RP, Komamura K, Shen YT, Bishop SP, Vatner SF. Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure. Am J Physiol 1993;265:H801-H809.
37. [37] Simmons WW, Moe GW, Grima EA, Howard RJ, Armstrong PW. Myocardial energetics and blood flow in acute rapid ventricular pacing. Can J Physiol Pharmacol 1994;72:6-10.
38. [38] Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-590.
39. [39] Speechly-Dick ME, Baxter GF, Yellon DM. Ischaemic preconditioning protects hypertophied myocardium. Cardiovasc Res 1994;28:1025-1029.
40. [40] Spinale FG, Crawford F Jr, Hewett KW, Carabello BA. Ventricular failure and cellular remodeling with chronic supraventricular tachycardia. J Thorac Cardiovasc Surg 1991;102:874-882.
41. [41] Spinale FG, Grine RC, Tempel GE, Crawford FA, Zile MR. Alterations in the myocardial capillary vasculature accompany tachycardia-induced cardiomyopathy. Basic Res Cardiol 1992;87:65-79.
42. [42] Spinale FG, Zellner JL, Tomita M, Crawford FA, Zile MR. Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circ Res 1991;69:1058-1067.
43. [43] Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M. Ventricular overdrive pacing-induced anti-ischemic effect: a conscious rabbit model of preconditioning. J Cardiovasc Pharmacol 1995;25:97-104.
44. [44] Tsuchida A, Liu Y, Liu GS, Cohen MV, Downey JM. Alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994;75:576-585.
45. [45] Van der Heide RS, Reimer KA, Jennings RB. Adenosine slows ischaemic metabolism in canine myocardium in vitro: relationship to ischaemic preconditioning. Cardiovasc Res 1993;27:669-673.
46. [46] Vatner DE, Sato N, Kiuchi K, Shannon RP, Vatner SF. Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failure. Circulation 1994;90:1423-1430.
47. [47] Wilson JR, Douglas P, Hickey WF, et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation 1987;75:857-867.
48. [48] Wilson JR, Lanoce V, Frey MJ, Ferraro N. Effect on peripheral arterioles of chronic fluid and sodium retention in heart failure. J Am Coll Cardiol 1988;12:202-208.
49. [49] Wolfe CL, Sievers RE, Visseren FL, Donnelly TJ. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 1993;87:881-892.
50. [50] Wolff MR, de-Tombe PP, Harasawa Y, et al. Alterations in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure. Circ Res 1992;70:516-529.
51. [51] Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-H1152.